Non-Animal Stabilized Hyaluronic Acid
Authors:
- 1 January 2005
- journal article
- Published by Springer Nature in BioDrugs
- Vol. 19 (1) , 23-30
Abstract
Hyaluronic acid (HA) is a major component of human synovial fluid, providing the rheologic properties (elasticity and viscosity) that enable the synovial fluid to perform lubricating and shock-absorbing functions within the healthy joint. Over the last 2 decades, HA preparations have become established in intra-articular therapy of osteoarthritis (OA), particularly OA of the knee. Existing HA preparations, both cross-linked and non-cross-linked, are all administered by courses of multiple injections, and all have been associated with variable success rates. The clinical profile of an HA preparation is inextricably linked to the product’s physicochemical properties. For example, the molecular structure of the HA affects the intra-articular residence time, which should in turn influence the duration of action post-injection. Non-animal stabilized hyaluronic acid (NASHA) is a new-generation HA preparation, produced wholly from non-animal sources. NASHA is stabilized using a carefully controlled cross-linking process, which increases the intra-articular residence time from hours to weeks. This facilitates single-injection treatment for OA without affecting the biocompatibility of HA. This review evaluates the properties of NASHA, including the available clinical data, in the context of previously developed HA preparations.Keywords
This publication has 31 references indexed in Scilit:
- Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the kneeOsteoarthritis and Cartilage, 2004
- Elimination of Stabilised Hyaluronan from the Knee Joint in Healthy MenClinical Pharmacokinetics, 2002
- Acute arthritis after intra-articular hyaluronate injection: onset of effusions without crystalAnnals of the Rheumatic Diseases, 2001
- Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritisJournal of Orthopaedic Research, 2000
- Hyaluronan or hylans for knee osteoarthritis?Drug and Therapeutics Bulletin, 1999
- Cross-linked Hyaluronan (Hylan B Gel): a New Injectable Remedy for Treatment of Vocal Fold Insufficiency - an Animal StudyActa Oto-Laryngologica, 1999
- Reactive Oxygen Species Contribute to Epidermal Hyaluronan Catabolism in Human Skin Organ CultureFree Radical Biology and Medicine, 1997
- Hyaluronic AcidDrugs, 1994
- Matrix engineeringBlood Coagulation & Fibrinolysis, 1991
- Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies.Annals of the Rheumatic Diseases, 1985